Cell lines derived from the haematologic system (e.g. chronic granulocytic leukaemia) showed relatively low BARX2 expression, while lower BARX2 expression was observed in LIHC cell lines. The gene discussed is BARX2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.